Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ionis
Ionis
AZ preps FDA filing for $3.6bn amyloidosis drug eplontersen
Pharmaforum
Tue, 06/21/22 - 10:57 am
AstraZeneca
eplontersen
Ionis
ATTR
Nearly 70% of Akcea's workforce is on the chopping block as Ionis executes major restructuring
Endpoints
Tue, 04/6/21 - 11:04 pm
Akcea
Ionis
layoffs
Sobi
Novartis elects to keep one heart drug, discard the other from option deal with Akcea, Ionis
Endpoints
Thu, 12/19/19 - 12:51 pm
Novartis
Akcea
Ionis
AKCEA-APO(a)-L
ACEKA-APOCIII-L
Pfizer's Vyndaqel franchise, buoyed by diagnoses, is poised for 'a decisive beat': analyst
Fierce Pharma
Fri, 10/18/19 - 07:45 pm
Pfizer
tafamidis
FDA
Vyndaqel
Alnylam
Ionis
ATTR amyloidosis
Alnylam's Onpattro back in the game against Ionis, thanks to NICE U-turn
Fierce Pharma
Tue, 07/9/19 - 06:32 pm
Ionis
Tegsedi
RNAi
Alnylam
Onpattro
NICE
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 04/28/19 - 10:00 pm
Regeneron
Sanofi
Praluent
FDA
Heron Therapeutics
HTX-011
Nabiva
Orchard Therapeutics
Akari Therapeutics
Aldeyra Therapeutics
BioTime
Audentes Therapeutics
Adaptimmune
GW Pharma
Ionis
Biogen
Ovid Therapeutics
TransMedics
IPOs
Trevi Therapeutics
GSK Hands Nerve Drug Back to Ionis as RNA Battle Heats Up
Xconomy
Fri, 08/11/17 - 11:37 am
GSK
Ionis
familial amyloid polyneuropathy
RNA
inotersen
Ionis-spinout Akcea prices IPO below expected range
Drug Delivery Business News
Sat, 07/15/17 - 11:23 am
Akcea
Ionis
IPOs
Volanesorsen
3 Biotechs With Tremendously Promising Pipelines
Motley Fool
Thu, 02/16/17 - 03:16 pm
biotech
Celgene
Ionis
Ligand Pharmaceuticals
Ionis Earns $28 Million from AstraZeneca for a New Drug to Treat Cancer
Yahoo
Fri, 12/16/16 - 09:45 am
Ionis
AstraZeneca
AZD4785
KRAS
cancer
Poised to launch a new drug for SMA, Biogen and Ionis shares jump on more promising PhIII data
Endpoints
Mon, 11/7/16 - 09:42 am
Biogen
Ionis
spinal muscular atrophy
Nusinersen
Biogen, Ionis Rise as Muscle Drug Hits Goal in Late-Stage Trial
Bloomberg
Mon, 08/1/16 - 09:45 am
Biogen
Ionis
clinical trials
Nusinersen
spinal muscular atrophy
Will Ionis And Biogen Get An Early Approval For Nusinersen?
Seeking Alpha
Thu, 05/12/16 - 04:53 pm
Biogen
Ionis
Nusinersen
spinal muscular atrophy